150 related articles for article (PubMed ID: 2077678)
1. Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma.
Ebihara T; Koyama S
Tohoku J Exp Med; 1990 Sep; 162(1):49-63. PubMed ID: 2077678
[TBL] [Abstract][Full Text] [Related]
2. [In vitro induction of cytotoxic activity against carcinomatous pleural or peritoneal lymphoid cells cultivated with cytokines, and an immunological phenotypic analysis of the effector cells].
Ebihara T; Koyama S
Gan No Rinsho; 1990 Apr; 36(5):604-10. PubMed ID: 2325266
[TBL] [Abstract][Full Text] [Related]
3. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
Blanchard DK; Kavanagh JJ; Sinkovics JG; Cavanagh D; Hewitt SM; Djeu JY
Cancer Res; 1988 Nov; 48(22):6321-7. PubMed ID: 2972357
[TBL] [Abstract][Full Text] [Related]
4. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
[TBL] [Abstract][Full Text] [Related]
5. Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma.
Ebihara T; Fukao K; Koyama S
Cancer; 1990 Sep; 66(5):923-9. PubMed ID: 2167147
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.
Ebihara T; Koyama S; Fukao K; Osuga T
Cancer Immunol Immunother; 1989; 28(3):218-24. PubMed ID: 2522349
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.
Koyama S; Ebihara T; Fukao K; Osuga T
Jpn J Cancer Res; 1989 Feb; 80(2):150-7. PubMed ID: 2498249
[TBL] [Abstract][Full Text] [Related]
8. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
9. [Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2].
Itoh K; Shiiba K; Ebina N; Anzai R; Ouchi A; Matsuno S
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):781-90. PubMed ID: 8377752
[TBL] [Abstract][Full Text] [Related]
10. Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients.
Chen YM; Yang WK; Whang-Peng J; Tsai WY; Hung YM; Yang DM; Lin WC; Perng RP; Ting CC
J Immunother; 1997 Sep; 20(5):354-64. PubMed ID: 9336742
[TBL] [Abstract][Full Text] [Related]
11. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
[TBL] [Abstract][Full Text] [Related]
12. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
Amirghofran Z; Sheikhi AK; Kumar PV; Saberi Firouzi M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):443-8. PubMed ID: 12200601
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous lymphokine-activated killer cell precursor populations. Development of a monoclonal antibody that separates two populations of precursors with distinct culture requirements and separate target-recognition repertoires.
Fox BA; Rosenberg SA
Cancer Immunol Immunother; 1989; 29(3):155-66. PubMed ID: 2786456
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interleukin-2-activated intracavitary lymphocytes: phenotypic characteristics and effector function.
Umiel T; Monselise J; Klein T; Rakovsky E; Fenig E; Lurie H; Adler A
J Biol Response Mod; 1989 Aug; 8(4):409-21. PubMed ID: 2787838
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions.
Chen YM; Tsai CM; Whang-Peng J; Perng RP
J Interferon Cytokine Res; 2001 Apr; 21(4):249-56. PubMed ID: 11359656
[TBL] [Abstract][Full Text] [Related]
16. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
17. Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions.
Chao TY; Hwang WS; Yeh MY
Proc Natl Sci Counc Repub China B; 1995 Apr; 19(2):92-8. PubMed ID: 7624448
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
[TBL] [Abstract][Full Text] [Related]
19. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
Ferrini S; Miescher S; Zocchi MR; von Fliedner V; Moretta A
J Immunol; 1987 Feb; 138(4):1297-302. PubMed ID: 3100633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]